Prognosis of moderate coronary artery lesions in heart transplant patients

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 130-136

  Luyt, Charles Edouard ^a   Drobinski, Gérard ^a   Dorent, Richard ^a   Ghossoub, Jean Jacques ^a   Collet, Jean Philippe ^a   Choussat, Rémi ^a   Dalby, Miles ^a   Thomas, Daniel ^a   Gandjbakhch, Iradj ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GRAFT REJECTION; HEART GRAFT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VALIDATION PROCESS;

CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0037311987     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00491-6     Document Type: Article

References (26)

1. Johnson D.E., Alderman E.L., Schroeder J.S., et al. Transplant coronary artery disease histopathologic correlations with angiographic morphology. J Am Coll Cardiol. 17:1991;449-457.
2. Gao S., Schroeder J.S., Alderman E.L., et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. Circulation. 80:(supplIII):1989;III-100-105.
3. Johnson M.R. Transplant coronary disease nonimmunologic risk factors. J Heart Lung Transplant. 11:(suppl):1992;S124-132.
4. Gao S., Hunt S.A., Schroeder J.S., Alderman E.L., Hill I.R., Stinson E.B. Early development of accelerated graft coronary artery disease risk factors and course. J Am Coll Cardiol. 28:1996;6673-6679.
5. Costenzo M.R., Naftel D.C., Pritzler M.R., et al. Heart transplantation coronary artery disease detected by angiography a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac transplant research database. J Heart Lung Transplant. 17:1998;744-753.
6. Fellstrom B., Backman U., Larsson E., Zezina L. Immunologic and nonimmunologic risk factors of chronic rejection. Transplant Proc. 31:1999;1304-1305.
7. Gao S., Alderman E.L., Schroeder J.S., Silverman J.F., Hunt S.A. Accelerated coronary vascular disease in the heart transplant patient coronary arteriographic findings. J Am Coll Cardiol. 12:1988;334-340.
8. Brunner-La Rocca H.P., Schneider J., Künzli A., Turina M., Kiowski W. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Transplantation. 65:1998;538-543.
9. Loebe M., Schüler S., Zais O., Warneke H., Fleck E., Hetzer R. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant. 9:1990;707-711.
10. Petrossian G.A., Nichols A.B., Marboe C.C., et al. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation. 80:(supplII):1989;III-122-125.
11. Hornick P., Smith J., Pomerance A., et al. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of "early" transplant-associated coronary artery disease. Circulation. 96:(supplII):1997;II-148-153.
12. Barbir M., Kushwaha S., Hunt B., et al. Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet. 340:1992;1500-1502.
13. Park J.W., Merz M., Braun P., Vermeltfoort M. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation. J Heart Lung Transplant. 15:1996;572-579.
14. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 333:1995;621-627.
15. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. Circulation. 96:1997;1398-1402.
16. Carrier M., Rivard M., Kostuk W., et al. The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE study. Can J Cardiol. 15:1999;1337-1344.
17. Keogh A., Macdonald P., Kaan A., Aboyoun C., Spratt P., Mundy J. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant. 19:2000;529-537.
18. Orourke B., Barbir M., Banner N., Yacoub M. Improved survival by long term statin therapy following cardiac transplantation correlates with lipid lowering effect. J Heart Lung Transplant. 21:2002;119-120.
19. Schroeder J.S., Gao S., Alderman E.L., et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med. 328:1993;164-170.
20. Gheissari A., Yokoyama T., Hendel J., Capouya E., Fuentes J., Jimenez P. Diltiazem prevents accelerated graft coronary artery disease in heart transplant recipients. Transplant Proc. 27:1995;2625-2627.
21. Schnetzler B., Drobinski G., Dorent R., et al. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant. 19:2000;557-565.
22. Dempsey S.J., D'Amico C., Weintraub W.S., et al. Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invas Cardiol. 12:2000;311-315.
23. Jain S.P., Ramee S.R., White C.J., et al. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol. 32:1998;1636-1640.
24. Wong P.M., Piamsomboon C., Mathur A., et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol. 82:1998;239-241.
25. Heublein B., Pethig K., Maass C., Wahlers T., Haverich A. Coronary artery stenting in cardiac allograft vascular disease. Am Heart J. 134:1997;930-938.
26. Redonnet M., Tron C., Koning R., et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. Transplant Proc. 32:2000;463-465.